Clinical Trials
3 trialsNCT02546661 2025-12-29
BISCAY
AstraZeneca
Phase 1 Active not recruiting
NCT00979134 2019-03-15
Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
AstraZeneca
Phase 1 Terminated
NCT01213160 2016-06-29
Study to Assess Safety and Tolerability of AZD4547 in Japanese Patient
AstraZeneca
Phase 1 Completed